NCT00401505View on ClinicalTrials.gov

Rubella Susceptibility in Multiparous Women

CompletedOBSERVATIONAL
Enrollment

310

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

September 30, 2012

Study Completion Date

September 30, 2012

Conditions
RubellaVaccine
Trial Locations (1)

M5B 1W8

St. Michael's Hospital, Toronto

All Listed Sponsors
lead

Unity Health Toronto

OTHER

NCT00401505 - Rubella Susceptibility in Multiparous Women | Biotech Hunter | Biotech Hunter